MICHAEL JAMES OVERMAN to Treatment Failure
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Treatment Failure.
Connection Strength
0.164
-
Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater. Oncologist. 2018 03; 23(3):277-e26.
Score: 0.117
-
Worsening of thrombotic thromboctyopenic purpura symptoms associated with desmopressin administration. Thromb Haemost. 2004 Oct; 92(4):886-7.
Score: 0.047